Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group

• Published in: Journal of hematology and oncology Vol. 9; no. 1; p. 133
• Main Authors: Laszlo, George S, Alonzo, Todd A, Gudgeon, Chelsea J, Harrington, Kimberly H, Kentsis, Alex, Gerbing, Robert B, Wang, Yi-Cheng, Ries, Rhonda E, Raimondi, Susana C, Hirsch, Betsy A, Gamis, Alan S, Meshinchi, Soheil, Walter, Roland B
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 30.11.2016; BioMed Central; BMC
• Subjects: Erratum

The original article [1] contains an omission of information in the Financial support sub-section of the Declarations section. The authors would like to acknowledge the Andrew McDonough B+ Foundation for financial support of co-author Dr Yi-Cheng Wang throughout this study, and regret this inadverte...